TCM
Tekla Capital Management Portfolio holdings
AUM
$2.56B
1-Year Return
18.15%
This Quarter Return
+1.3%
1 Year Return
+18.15%
3 Year Return
+62.34%
5 Year Return
+140.22%
10 Year Return
+499.57%
AUM
$2.45B
AUM Growth
-$11.8M
(-0.48%)
Cap. Flow
-$7.06M
Cap. Flow
% of AUM
-0.29%
Top 10 Holdings %
Top 10 Hldgs %
40.31%
Holding
207
New
13
Increased
45
Reduced
58
Closed
10
Top Buys
| 1 |
Vertex Pharmaceuticals
VRTX
|
$8.44M |
| 2 |
Intuitive Surgical
ISRG
|
$8.07M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
$7.96M |
| 4 |
Boston Scientific
BSX
|
$6.82M |
| 5 |
Gilead Sciences
GILD
|
$5.86M |
Top Sells
| 1 |
Biogen
BIIB
|
$21M |
| 2 |
Illumina
ILMN
|
$14.4M |
| 3 |
Elevance Health
ELV
|
$10.7M |
| 4 |
AGN
Allergan plc
AGN
|
$8.2M |
| 5 |
Welltower
WELL
|
$6.93M |
Sector Composition
| 1 | Healthcare | 95.11% |
| 2 | Real Estate | 2.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Smith & Nephew
SNN
$16.4B
| $7M | 0.29% |
160,734
-24,744
| -13% | -$1.08M |
|
|
PVLA
77
Palvella Therapeutics, Inc. Common Stock
PVLA
$587M
| $6.81M | 0.28% |
18,116
-7,976
| -31% | -$3M |
|
78
Ventas
VTR
$30.7B
| $6.73M | 0.27% |
98,496
| – | – |
|
|
LTC
79
LTC Properties
LTC
$1.67B
| $6.64M | 0.27% |
145,421
| – | – |
|
80
Coherus Oncology, Inc. Common Stock
CHRS
$156M
| $6.44M | 0.26% |
291,419
-23,743
| -8% | -$525K |
|
81
ResMed
RMD
$39.7B
| $6.36M | 0.26% |
52,110
-16,864
| -24% | -$2.06M |
|
82
PTC Therapeutics
PTCT
$4.42B
| $6.28M | 0.26% |
139,608
+70,956
| +103% | +$3.19M |
|
83
Galapagos
GLPG
$2.04B
| $6.26M | 0.26% |
48,525
| – | – |
|
84
Acadia Healthcare
ACHC
$2.18B
| $6.05M | 0.25% |
173,155
| – | – |
|
|
ZGNX
85
DELISTED
Zogenix, Inc.
ZGNX
| $5.93M | 0.24% |
124,148
+34,386
| +38% | +$1.64M |
|
86
Labcorp
LH
$22.8B
| $5.43M | 0.22% |
36,578
-16,567
| -31% | -$2.46M |
|
|
IMMU
87
DELISTED
Immunomedics Inc
IMMU
| $5.4M | 0.22% |
389,313
+101,626
| +35% | +$1.41M |
|
|
DOC
88
DELISTED
PHYSICIANS REALTY TRUST
DOC
| $5.3M | 0.22% |
303,908
| – | – |
|
|
WCG
89
DELISTED
Wellcare Health Plans, Inc.
WCG
| $5.1M | 0.21% |
17,886
-1,400
| -7% | -$399K |
|
90
Ligand Pharmaceuticals
LGND
$3.27B
| $5.03M | 0.21% |
70,620
+22,698
| +47% | +$1.62M |
|
|
EPZM
91
DELISTED
Epizyme, Inc
EPZM
| $5.02M | 0.2% |
399,604
+110,200
| +38% | +$1.38M |
|
92
Iovance Biotherapeutics
IOVA
$774M
| $4.88M | 0.2% |
199,073
-17,835
| -8% | -$437K |
|
93
Bio-Techne
TECH
$8.11B
| $4.52M | 0.18% |
86,804
| – | – |
|
94
Alkermes
ALKS
$4.77B
| $4.46M | 0.18% |
198,048
| – | – |
|
95
Steris
STE
$23.9B
| $4.32M | 0.18% |
28,981
-19,022
| -40% | -$2.83M |
|
|
ICPT
96
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $4.29M | 0.17% |
53,857
-5,418
| -9% | -$431K |
|
97
Acadia Pharmaceuticals
ACAD
$4.31B
| $4.28M | 0.17% |
160,147
+55,433
| +53% | +$1.48M |
|
98
Bausch Health
BHC
$2.65B
| $4.26M | 0.17% |
168,812
| – | – |
|
99
United Therapeutics
UTHR
$17.4B
| $4.22M | 0.17% |
54,094
+12,833
| +31% | +$1M |
|
100
AnaptysBio
ANAB
$608M
| $4.22M | 0.17% |
74,798
+8,953
| +14% | +$505K |
|